,

Free Anti-Golimumab

Detecting the development of Anti-drug antibodies (ADAs) against Golimumab in patients being treated with Golimumab for chronic autoimmune and inflammatory conditions

Therapeutic Drug Monitoring (TDM) is to optimize biologic treatment for an individual patient.
AFIAS Free Anti-Golimumab can detect the presence of anti-drug antibodies against
Golimumab, requiring only a small amount of human serum or whole blood, and delivering results in a mere 10 minutes.
This allows physicians to verify the presence of anti-drug antibodies immediately before the next administration.

Reviews

There are no reviews yet.

Be the first to review “Free Anti-Golimumab”

Your email address will not be published. Required fields are marked *

Scroll to Top